In a report published Thursday, Credit Suisse analyst Chris Carter upgraded the rating on WellCare Health Plans WCG from Neutral to Outperform, but lowered the price target from $77.00 to $70.00.
In the report, Credit Suisse noted, “We are upgrading shares of WCG to Outperform (from Neutral) as we see attractive risk/reward to our new $70 TP (previously $77). YTD, WCG has underperformed the HMOs (by -17%) and S&P500 (by -16%) given a re-rating in shares following lower 2014 guidance. We view that guidance as achievable and coupled with greater visibility on the 2015 MA rate outlook, believe the stock is poised to grind higher. From a LT perspective, we view WCG as an attractive way to play the favorable growth trends in both Medicaid and Medicare. We also believe take-out potential should provide valuation support and a free call option.”
WellCare Health Plans closed on Wednesday at $59.20.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in